Literature DB >> 2992502

Atrial natriuretic factor increases cyclic GMP and inhibits cyclic AMP in rat renal papillary collecting tubule cells in culture.

S Ishikawa, T Saito, K Okada, T Kuzuya, K Kangawa, H Matsuo.   

Abstract

The present study was undertaken to determine whether human atrial natriuretic factor (hANF) produces guanosine-3', 5'-monophosphate (cGMP) and alters arginine vasopressin (AVP)- and forskolin (F)- induced adenosine-3', 5'-monophosphate (cAMP) production in the cultured rat renal papillary collecting tubule cells. hANF increased cellular cGMP levels in a dose dependent manner. AVP and F, however, did not affect cGMP production. hANF significantly inhibited AVP- and F-stimulated cAMP levels, but hANF by itself did not affect cellular cAMP production. Since F activates adenylate cyclase at a step of catalytic unit and the cellular action of AVP to activate adenylate cyclase is mediated through receptor-catalytic units, the present results indicate that hANF may directly inhibit the AVP- and F-stimulated adenylate cyclase in renal papillary collecting tubules.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992502     DOI: 10.1016/0006-291x(85)91735-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Ultracytochemistry as a tool for the study of the cellular and subcellular localization of membrane-bound guanylate cyclase (GC) activity. Applicability to both receptor-activated and receptor-independent GC activity.

Authors:  Maria Grazia Rambotti; Antonio Spreca; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Atrial natriuretic peptide effects on cGMP and cAMP contents in microdissected glomeruli and segments of the rat and rabbit nephrons.

Authors:  D Chabardès; M Montégut; M Mistaoui; D Butlen; F Morel
Journal:  Pflugers Arch       Date:  1987-04       Impact factor: 3.657

3.  Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats.

Authors:  H Nonoguchi; M A Knepper; V C Manganiello
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.

Authors:  C L Huang; H E Ives; M G Cogan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.

Authors:  R C Willenbrock; J Tremblay; R Garcia; P Hamet
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system.

Authors:  M B Anand-Srivastava; J Gutkowska; M Cantin
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

7.  Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase.

Authors:  M B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

8.  Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.

Authors:  M A Lee; R E West; J Moss
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Evidence for particulate guanylate cyclase in rat kidney after stimulation by atrial natriuretic factor. An ultracytochemical study.

Authors:  M G Rambotti; C Saccardi; A Spreca
Journal:  Histochem J       Date:  1990-09

Review 10.  Atrial natriuretic factor: physiologic actions and implications in congestive heart failure.

Authors:  B S Edwards; R S Zimmerman; J C Burnett
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.